Sartorius Aktiengesellschaft
Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services worldwide. The company offers biosensors and kits, compliance tools, systems software, label-free detection systems, and SPR systems; live-cell analysis systems, flo…
Medical - Instruments & Supplies
DE, Göttingen [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
Fundamentals
Valuation
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| EV/EBITDA | -35.12 | 94.19 | 145.18 | |
| Graham Fair Price | -17.03 | 21.71 | 26.17 | |
| PEG | 2757.72 | -2.70 | 0.09 | |
| Price/Book | -19.02 | 6.91 | 8.53 | |
| Price/Cash Flow | 110.53 | -200.45 | 95.21 | |
| Prices/Earnings | 96.45 | 125.76 | 64.02 | |
| Price/Sales | 8.50 | 22.53 | 20.76 | |
| Price/FCF | 110.53 | -200.45 | 95.21 | |
| Naive Interpretation | member | |||
01 - Valuation ·
Weak
Fundamentals
Profitability
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Gross Profit Margin | 24.07 | 0.48 | 0.39 | |
| Operating Margin | 123.20 | 0.18 | 0.08 | |
| ROA | -51.11 | < 0.005 | < 0.005 | |
| ROE | 0.03 | 0.01 | -58.78 | |
| ROIC | < 0.005 | 0.01 | 199.17 | |
| Naive Interpretation | member | |||
02 - Profitability ·
Not Interpreted
Fundamentals
Financial Growth
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Debt QOQ | -0.02 | < 0.005 | -114.25 | |
| Dividends QOQ | 0.00 | -1.00 | -100.00 | |
| EBIT QOQ | -0.17 | 1.15 | 598.60 | |
| EPS QOQ | 6.77 | -0.47 | -93.13 | |
| FCF QOQ | 3.03 | -1.50 | -50.56 | |
| Revenue QOQ | 0.05 | -0.04 | -26.32 | |
| Naive Interpretation | member | |||
03 - Financial Growth ·
Weak
Fundamentals
Leverage & Liquidity
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Assets Turnover | n.A. | n.A. | n.A. | |
| Days Inventory Outstanding (DIO) | 179.90 | 218.45 | 21.43 | |
| Days Sales Outstanding (DSO) | 45.83 | 53.99 | 17.82 | |
| Inventory Turnover | 0.50 | 0.41 | -17.65 | |
| Debt/Capitalization | 0.72 | 0.66 | -8.92 | |
| Quick Ratio | 0.62 | 1.19 | 91.93 | |
| Naive Interpretation | member | |||
04 - Leverage & Liquidity ·
Weak
Fundamentals
Per Share Metrics
| Metric | Q4 | Q1 | Δ in % | |
|---|---|---|---|---|
| Book Value | 30.22 | 39.05 | 29.23 | |
| Cash | 5.76 | 16.76 | 190.89 | |
| Capex | -1.84 | -1.88 | -2.07 | |
| Free Cash Flow | 2.71 | -1.35 | -50.30 | |
| Revenue | 12.42 | 11.98 | -3.55 | |
| Naive Interpretation | member | |||
05 - Per Share Metrics ·
Weak
Fundamentals
Financial Health
06 - Financial Health ·
Bad